Back
Evolus, Inc. 10K Form
Sell
30
EOLS
Evolus, Inc.
Last Price:
$6.82
Seasonality Move:
56.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EOLS News And Ratings
See the #1 stock for the next 7 days that we like better than EOLS
EOLS Financial Statistics
Sales & Book Value
| Annual Sales: | $266.3M |
|---|---|
| Cash Flow: | $-16.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.44 |
| Price / Book: | 116.53 |
Profitability
| EPS (TTM): | -0.91250 |
|---|---|
| Net Income (TTM): | $-58.6M |
| Gross Margin: | $180M |
| Return on Equity: | -5666.82% |
| Return on Assets: | -26.07% |
Evolus, Inc. Earnings Forecast
Key Evolus, Inc. Financial Ratios
-
The Gross Profit Margin over the past 10 years for EOLS is 67.59%.
-
The Selling, General & Administrative Expenses for EOLS have been equal to 74.37% of Gross Profit Margin.
-
The Research & Development expenses have been 3.44% of Revenue.
-
The Net Earning history of EOLS is -18.94% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 5 years.
Evolus, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | EOLS |
| CUSIP: | 30052C |
| Website: | evolus.com |
Debt
| Debt-to-Equity Ratio: | -5.39 |
|---|---|
| Current Ratio: | 2.02 |
| Quick Ratio: | 1.48 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 32.12 |
EOLS Technical Analysis vs Fundamental Analysis
Sell
30
Evolus, Inc. (EOLS)
is a Sell
Is Evolus, Inc. a Buy or a Sell?
-
Evolus, Inc. stock is rated a SellThe current Evolus, Inc. [EOLS] share price is $6.81. The Score for EOLS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.